Latest filing published 04 Sept 2026 for Veracyte, INC., €141k. Read the official filing
Phillip G. Febbo (senior executive) discloses dealings in 2 companies, chiefly Veracyte, Inc. and Illumina, Inc. Between 11 June 2021 and 4 September 2026, the trades on record add up to 26 filings.
On the market, this insider has only sold: 6 sales, €1.2M in total. Other entries cover 18 share grants and 2 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
The record was last updated on 4 September 2026 with a share grant (€141k) in Veracyte, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations